Skip to Content
MIT Technology Review

A Tale of Two Drugs

November 2013

Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.

Read the issue

Letter from the editor

The Legacy of Ann Wolpert


Past issues